Browsing Tag
multi-cancer early detection
3 posts
GRAIL (Nasdaq: GRAL) files FDA application for Galleri test, aiming to redefine how cancer is detected in asymptomatic patients
GRAIL files FDA approval for Galleri, its blood-based test for early cancer detection. Find out what it means for diagnostics, payers, and public health.
GRAIL stock surges 14% after $110m Samsung deal to expand Galleri test in Asia
GRAIL stock jumps 14% after Samsung's $110M investment and Asia commercialization deal for its Galleri cancer test. Learn how investors are reacting.
GRAIL’s new REACH study of Galleri MCED test set to change future of cancer detection for seniors – Find out how
GRAIL, Inc. (Nasdaq: GRAL), a healthcare company renowned for its mission to detect cancer early when it can…